In the modeling phase, six TAAbs (anti-CEP55, anti-CKS1B, anti-ECT2, anti-KIF2C, anti-SURV, and anti-TPX2) remained elevated in ESCC cases compared with both benign esophageal disease and normal controls. This evidence concerns the gene TPX2 and esophageal squamous cell carcinoma.